Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells-Reference-Cited by-同舟云学术

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Published:2014-09 Issue: Volume:62 Page:51-59
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Perfeito Rita,Lázaro Diana F.,Outeiro Tiago F.,Rego A. Cristina

Funder

FCT

COMPETE—Programa Operacional Factores de Competitividade”, QREN

European Union

EMBO

DFG Center for Nanoscale Microscopy

Molecular Physiology of the Brain

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference56 articles.

1. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease;Anderson;J. Biol. Chem.,2006

2. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease;Appel-Cresswell;Mov. Disord.,2013

3. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease;Azeredo da;Hum. Mol. Genet.,2009

4. PLK2 modulates α-synuclein aggregation in yeast and mammalian cells;Basso;Mol. Neurobiol.,2013

5. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms;Berg;Neurochem. Res.,2007

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid FRET Assay for the Early Detection of Alpha-Synuclein Aggregation in Parkinson’s Disease;ACS Chemical Neuroscience;2024-03-20

2. Role of Autophagy and Mitophagy in Neurodegenerative Disorders;CNS & Neurological Disorders - Drug Targets;2024-03

3. Nanozyme enabled protective therapy for neurological diseases;Nano Today;2024-02

4. Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging;Scientific Reports;2024-01-30

5. Glucose, glycolysis, and neurodegenerative disorders;Glycolysis;2024